PR Newswire
NEW YORK
,
Jan. 14, 2021
/PRNewswire/ —
If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16
th
Floor
New York
, NY 10036
(212) 682-3025
(888) 593-4771
[email protected]
Cancer Genetics, Inc. (NASDAQ: CGIX)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of
Cancer Genetics, Inc. (NASDAQ: CGIX)
in connection with the company’s proposed merger with privately held StemoniX, Inc. (“StemoniX”). Under the terms of the agreement, CGIX will acquire all of the outstanding shares of StemoniX in exchange for approximately 78% of CGIX’s outstanding common stock. The combined company will continue to trade on the NASDAQ, but CGIX shareholders will control only 22% of the surviving entity. If you own CGIX shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:
New Providence Acquisition Corp. (NASDAQ: NPA)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of
New Providence Acquisition Corp. (NASDAQ: NPA)
in connection with the company’s proposed merger with AST & Science LLC (“AST”). Under the terms of the merger agreement, NPA will acquire AST through a reverse merger that will result in AST becoming a publicly traded company. If you own NPA shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:
Thunder Bridge Acquisition II Ltd. (NASDAQ: THBR)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of
Thunder Bridge Acquisition II Ltd. (NASDAQ: THBR)
in connection with the company’s proposed merger with indie Semiconductor. Under the terms of the merger agreement, THBR will acquire indie Semiconductor through a reverse merger that will result in indie Semiconductor becoming a publicly traded company. If you own THBR shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:
GigCapital2, Inc. (NYSE: GIX)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of
GigCapital2, Inc. (NYSE: GIX)
in connection with the company’s proposed merger with privately held digital healthcare provider UpHealth Holdings, Inc. (“UpHealth”) and privately held telemedicine provider Cloudbreak Health, LLC (“Cloudbreak”). GIX will combine with Uphealth and Cloudbreak via a reverse-merger to create a single publicly- traded digital healthcare company. If you own GIX shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:
View original content to download multimedia:
http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-reminds-cgix-npa-thbr-and-gix-shareholders-about-its-ongoing-investigations-301208934.html
SOURCE WeissLaw LLP
